Clonal evolution in Philadelphia chromosome negative cells following successful treatment with Imatinib of a CML patient: clinical and biological features of a myelodysplastic syndrome

被引：17

作者：

Alimena, G ^{[1
]}

Breccia, M ^{[1
]}

Mancini, M ^{[1
]}

Ferranti, G ^{[1
]}

De Felice, L ^{[1
]}

Gallucci, C ^{[1
]}

Mandelli, F ^{[1
]}

机构：

[1] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, I-00161 Rome, Italy

来源：

LEUKEMIA | 2004年 / 18卷 / 02期

关键词：

D O I：

10.1038/sj.leu.2403210

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：361 / 362

页数：2

共 10 条

[1] Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8 [J].

Andersen, MK ;

Pedersen-Bjorgaard, J ;

Kjeldsen, L ;

Dufva, IH ;

Brondum-Nielsen, K .

LEUKEMIA, 2002, 16 (07) :1390-1393

[2] Hematopathologic and cytogenetic findings in imatinib mesylate-treated chronic myelogenous leukemia patients: 14 months' experience [J].

Braziel, RM ;

Launder, TM ;

Druker, BJ ;

Olson, SB ;

Magenis, RE ;

Mauro, MJ ;

Sawyers, CL ;

Paquette, RL ;

O'Dwyer, ME .

BLOOD, 2002, 100 (02) :435-441

[3] Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority [J].

Bumm, T ;

Müller, C ;

Al-Ali, HK ;

Krohn, K ;

Shepherd, P ;

Schmidt, E ;

Leiblein, S ;

Franke, C ;

Hennig, E ;

Friedrich, T ;

Krahl, R ;

Niederwieser, D ;

Deininger, MWN .

BLOOD, 2003, 101 (05) :1941-1949

[4] Interferon-α, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemia [J].

Burchert, A ;

Wölfl, S ;

Schmidt, M ;

Brendel, C ;

Denecke, B ;

Cai, D ;

Odyvanova, L ;

Lahaye, T ;

Müller, MC ;

Berg, T ;

Gschaidmeier, H ;

Wittig, B ;

Hehlmann, R ;

Hochhaus, A ;

Neubauer, A .

BLOOD, 2003, 101 (01) :259-264

[5] Fatal myelodysplastic syndrome developing during therapy with imatinib mesylate and characterised by the emergence of complex Philadelphia negative clones [J].

Chee, YL ;

Vickers, MA ;

Stevenson, D ;

Holyoake, TL ;

Culligan, J .

LEUKEMIA, 2003, 17 (03) :634-635

[6] Flt3L induces the ex-vivo amplification of umbilical cord blood committed progenitors and early stem cells in short-term cultures [J].

De Felice, L ;

Di Pucchio, T ;

Mascolo, MG ;

Agostini, F ;

Breccia, M ;

Guglielmi, C ;

Ricciardi, MR ;

Tafuri, A ;

Screnci, M ;

Mandelli, F ;

Arcese, W .

BRITISH JOURNAL OF HAEMATOLOGY, 1999, 106 (01) :133-141

[7] Myelodysplastic subclones in chronic myeloid leukemia: implications for imatinib mesylate therapy [J].

Goldberg, SL ;

Madan, RA ;

Rowley, SD ;

Pecora, AL ;

Hsu, JW ;

Tantravahi, R .

BLOOD, 2003, 101 (02) :781-781

[8]

Marktel S, 2003, HAEMATOLOGICA, V88, P260

[9] Sustained, clonal karyotype abnormalities in the Philadelphia chromosome negative cells of CML patients successfully treated with imatinib [J].

Meeus, P ;

Demuynck, H ;

Martiat, P ;

Michaux, L ;

Wouters, E ;

Hagemeijer, A .

LEUKEMIA, 2003, 17 (02) :465-467

[10] Simultaneous occurrence of a t(9;22) (Ph) with a t(2;11) in a patient with CML and emergence of a new clone with the t(2;11) alone after imatinib mesylate treatment [J].

Royer-Pokora, B ;

Hildebrandt, B ;

Redmann, A ;

Herold, C ;

Kronenwett, R ;

Haas, R ;

Drechsler, M ;

Wieland, C .

LEUKEMIA, 2003, 17 (04) :807-810

← 1 →